Company
Headquarters: Camberwell, VIC, Australia
CEO: Mr. Robert Read B.A., BA(Psych), BComm(Mgt), GAICD
A$123.1 Million
AUD as of Jan. 1, 2024
US$83.8 Million
Company | Market Cap (USD) |
---|---|
GE HealthCare | $34.86 B |
Veeva Systems Inc. | $29.97 B |
M3, Inc. | $11.24 B |
Change Healthcare Inc. | $9.03 B |
Signify Health, Inc. | $8.38 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
MedAdvisor Limited, together with its subsidiaries, develops and delivers software for personal medication management in Australia, the United States, the United Kingdom, and Asia. The company provides MedAdvisor, a medication and adherence platform that focuses on improving health outcomes by connecting health professionals with their patients using technology and enhancing medication adherence through health programs using mobile and web apps. MedAdvisor Limited was incorporated in 2010 and is headquartered in Camberwell, Australia.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
MedAdvisor Limited has the following listings and related stock indices.
Stock: ASX: MDR wb_incandescent